PCRI Attends Prostate Cancer Symposium

Helpline Facilitator Jim O’Hara (right) with PCRI Co-founder Stephen Strum, MD

PCRI was well-represented at the ASCO Prostate Cancer Symposium in San Francisco, CA (Feb. 24-26, 2006). Executive Director, Brad Guess, along with Program Director Harry Pinchot and Educational Facilitator Jim O’Hara attended many of the sessions and manned an exhibit highlighting PCRI services. Co-founders Mark Scholz, MD and Stephen Strum, MD plus several of PCRI’s Medical Advisors were also in attendance.

The 2006 Prostate Cancer Symposium was co-sponsored and developed by the American Society of Clinical Oncology (ASCO), the American Society for Therapeutic Radiology and Oncology (ASTRO), the Prostate Cancer Foundation (PCF), and the Society of Urologic Oncology (SUO). It featured over 50 talks by prominent physicians and scientists and more than 350 poster presentations.

For more information on the material provided at the Symposium:

Highlights of the 2006 Prostate Cancer Symposium

You can read a report prepared by Merel Nissenberg, President of the National Alliance of State Prostate Cancer Coalitions (NASPCC)

You can listen to Audio recordings of most of the talks and view the slides on the ASCO website.

You can view most of the poster abstracts presented at the conference on the ASCO website.

The categories covered at the symposium included:

Biology of Prostate Cancer
Cancer Genetics
Developmental Therapeutics
Hormone-Refractory Prostate Cancer
Tumor & Cell Biology

Early and Localized Disease
Complications of Treatment
Developmental Therapeutics
Diagnosis, Staging and Treatment

Epidemiology, Risk Factors, Prevention and Screening
Epidemiology
Risk Factors
Screening
Health Services Research
Outcomes Measurement
Practice Management and Professional Issues
Quality of Life and Survivorship

Locally Advanced and Recurrent Disease
Androgen Deprivation Therapy
Climbing PSA in Hormone Therapy-Naïve Patients
Complications of Treatment
Developmental Therapeutics
Diagnosis, Staging and Treatment
Hormone-Refractory Prostate Cancer (treatment of)
Supportive Care

Prostate Cancer Research Institute (PCRI)
 

Material provided by PCRI is intended for educational purposes for discussion with your physician and should not be considered as medical advice. Information and opinions expressed on this website are not an endorsement by PCRI for any treatment, product or service.